Clinical Trial Update: Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update showing completion of a Phase 1 study for a Salmonella Typhi Vi O-Acetyl Pectin-rEPA conjugate vaccine for typhoid fever.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Typhoid Fever

Drugs mentioned

• Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine (Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Typhoid Fever | Phase 1 | Status: COMPLETED